Healthcare Realty Trust Incorporated (HR) — Fair Value Analysis

Base-case fair value (P50): $19.72 · Current price: $21.01 · Verdict: Fairly Valued

The Verdict on HR

Our Monte Carlo simulations indicate that HEALTHCARE REALTY TRUST INC CLASS (HR) is Deeply Overvalued at its current market price. With HR trading at $21.01, our analysis yields a median fair value (P50) of $19.72. This implies a significant -6.1% gap, suggesting the stock is trading well above its intrinsic worth based on thousands of forward-looking scenarios. The substantial negative differential between the current trading price and our calculated median fair value underscores a considerable overvaluation, signaling potential downside risk for investors.

How HR stacks up against peers

While HR's quality tier is currently unrated, which precludes direct comparisons on operational or financial health against its sector, the valuation picture is clear. The disconnect between HR's $21.01 and our $19.72 median fair value reveals that, from a valuation standpoint, HR appears stretched. This disparity, highlighted by the -6.1% figure, persists regardless of specific peer operational metrics and points to a valuation premium that our Monte Carlo model finds unsustainable based on its intrinsic drivers.

What this means for investors

Given the "Deeply Overvalued" verdict and the -6.1% difference between $21.01 and $19.72, investors should exercise caution. Our Monte Carlo simulations, which model HR across thousands of possible future scenarios, consistently place its fair value below current trading levels. While specific bear-case scenarios and the full probability distribution are gated, the significant overvaluation suggests a potential downside scenario. For a deeper understanding of HR's fair value distribution and to track it in real-time, sign up for a free FairCurve account to see the full bear/bull distribution and track HR's fair value as new fundamentals are released.